Related Experiment Video
Updated: Jun 25, 2026
06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Tobacco smoke-related diffuse lung diseases
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Seminars in Respiratory and Critical Care Medicine
|February 18, 2009
Summary
Cigarette smoking causes diffuse lung diseases like desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Smoking cessation is key for managing these conditions, though treatment effectiveness varies.
Area of Science:
- Pulmonology
- Toxicology
- Pathology
Background:
- Chronic tobacco smoke inhalation is linked to diffuse lung diseases.
- These conditions primarily affect young adult smokers and include desquamative interstitial pneumonia, respiratory bronchiolitis-associated interstitial lung disease, and pulmonary Langerhans cell histiocytosis.
- Smoking also increases the risk for other interstitial lung diseases, such as idiopathic pulmonary fibrosis.
Purpose of the Study:
- To review the spectrum of smoking-related interstitial and bronchiolar lung diseases.
- To highlight the importance of recognizing these conditions in clinical practice.
- To discuss management strategies, emphasizing smoking cessation.
Main Methods:
- Literature review of smoking-related diffuse lung diseases.
- Analysis of histopathologic and radiological features.
- Discussion of treatment modalities and their efficacy.
Main Results:
- Smoking-related lung diseases share overlapping features and include specific interstitial pneumonias and histiocytosis.
- Acute eosinophilic pneumonia is a distinct smoking-related condition that responds to corticosteroids.
- The efficacy of immunosuppressive treatments is limited, especially without smoking cessation.
Conclusions:
- Clinicians must recognize smoking-related interstitial lung diseases as a significant subset of interstitial lung diseases.
- Smoking cessation is the cornerstone of management for these conditions.
- Further research is needed to clarify the role of medical therapies beyond smoking cessation.
Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.